Brandon Hensinger, a published author, global speaker and entrepreneur, is President & Chief Executive Officer of Avrio Genetics, a company that provides life-changing reproductive, as well as personalized, genetic testing products and solutions to physicians and patients throughout the world. Brandon also leads the pandemic division of Avrio Genetics, Bio Testing Supplies, where his team is focused on providing industry leading viral testing solutions and educational support during the COVID pandemic.
He has been at the forefront of many innovative breakthroughs. Most notably, he led the launch of the world's first Non-Invasive PGT-A Technology, which is an embryo screening technology that uses non-invasive practices to help physicians choose healthy embryos for transfer, for women going through fertility treatments with Yikon Genomics.